Cargando…
Digital breast tomosynthesis compared to diagnostic mammographic projections (including magnification) among women recalled at screening mammography: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
BACKGROUND: Diagnostic mammography projections (DxMM) have been traditionally used in the assessment of women recalled after a suspicious screening mammogram. Digital breast tomosynthesis (DBT) reduces the tissue overlap effect, thus improving image assessment. Some studies have suggested DBT might...
Autores principales: | Canelo‐Aybar, Carlos, Carrera, Lourdes, Beltrán, Jessica, Posso, Margarita, Rigau, David, Lebeau, Annette, Gräwingholt, Axel, Castells, Xavier, Langendam, Miranda, Pérez, Elsa, Giorgi Rossi, Paolo, Van Engen, Ruben, Parmelli, Elena, Saz‐Parkinson, Zuleika, Alonso‐Coello, Pablo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982617/ https://www.ncbi.nlm.nih.gov/pubmed/33675147 http://dx.doi.org/10.1002/cam4.3803 |
Ejemplares similares
-
Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
por: Canelo-Aybar, Carlos, et al.
Publicado: (2021) -
Correction to: Preoperative breast magnetic resonance imaging in patients with ductal carcinoma in situ: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
por: Canelo-Aybar, Carlos, et al.
Publicado: (2022) -
Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC)
por: Canelo-Aybar, Carlos, et al.
Publicado: (2021) -
Recommendations from the European Commission Initiative on Breast Cancer for multigene testing to guide the use of adjuvant chemotherapy in patients with early breast cancer, hormone receptor positive, HER-2 negative
por: Giorgi Rossi, Paolo, et al.
Publicado: (2021) -
Healthcare providers’ adherence to breast cancer guidelines in Europe: a systematic literature review
por: Niño de Guzmán, Ena, et al.
Publicado: (2020)